Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02096874|
Recruitment Status : Unknown
Verified March 2014 by Saba al Rashaed, King Khaled Eye Specialist Hospital.
Recruitment status was: Recruiting
First Posted : March 26, 2014
Last Update Posted : March 26, 2014
|Condition or disease||Intervention/treatment||Phase|
|Non-proliferative Diabetic Retinopathy Proliferative Diabetic Retinopathy Diabetic Macular Edema||Drug: Bevacizumab||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Effect of Bevacizumab on Peripheral Retinal Changes as Imaged by Wide -Field Fluorescein Angiography in Diabetic Macular Edema|
|Study Start Date :||June 2013|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||June 2015|
Each study subject will recieve Intravitreal injection of 1.25mg/0.05 cc each 5 weeks for the first 3 months then PRN for six month.
Intravitreal injection of 1.25mg/0.05 cc each 5 weeks for the first 3 months then PRN for six month
Other Name: Avastin
- Peripheral retinal ischemia [ Time Frame: 24 weeks ]Change in peripheral retinal ischemia after intravitreal bevacizumab injection in non proliferative diabetic retinopathy and proliferative diabetic retinopathy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02096874
|Contact: Ovais M Shaikh, MD||(966) 4821234 ext firstname.lastname@example.org|
|Contact: Abdul Rahman Hommadi||(966)4821234 ext email@example.com|
|King Khaled Eye Specialist Hospital||Recruiting|
|Riyadh, Saudi Arabia, 11462|
|Principal Investigator:||Saba al Rashaed, MD||King Khaled Eye Specialist Hospital|